CLIN.L Share News (CLIN)

CLIN.L Information

There is currently no data for CLIN

UK earnings, trading statements calendar - next 7 days

Thu, 09th Sep 2021 16:01

Friday 10 September
no events scheduled
Monday 13 September
Abcam PLC	Full Year Results
Associated British Foods PLC	Trading Statement
Blackbird PLC	Half Year Results
City of London Investment Group PLC	Full Year Results
Dianomi PLC	Half Year Results
Gaming Realms PLC	Half Year Results
Greencoat Renewables PLC	Half Year Results
Henry Boot PLC	Half Year Results
ITM Power PLC	Full Year Results
MaxCyte Inc	Half Year Results
MP Evans Group PLC	Half Year Results
Spectral MD Holdings Ltd	Half Year Results
S4 Capital PLC	Half Year Results
SThree PLC	Q3 Results
Surface Transforms PLC	Half Year Results
Verici Dx PLC	Half Year Results
Xpediator PLC	Half Year Results
Tuesday 14 September
accesso Technology Group PLC	Half Year Results
Bluejay Mining PLC	Half Year Results
British Honey Co PLC	Half Year Results
CloudCall Group PLC	Half Year Results
Diurnal Group PLC	Full Year Results
Equals Group PLC	Half Year Results
Filta Group Holdings PLC	Half Year Results
Good Energy Group PLC	Half Year Results
Harworth Group PLC	Half Year Results
JD Sports Fashion PLC	Half Year Results
Kistos PLC	Half Year Results
Made.com Group PLC	Half Year Results
MJ Gleeson PLC	Full Year Results
NCC Group PLC	Full Year Results
Ocado Group PLC	Q3 Results
Ocean Outdoor Ltd	Half Year Results
Petra Diamonds Ltd	Full Year Results
Portmeirion Group PLC	Half Year Results
Property Franchise Group PLC	Half Year Results
Sanne Group PLC	Half Year Results
Smart Metering Systems PLC	Half Year Results
Staffline Group PLC	Half Year Results
STM Group PLC	Half Year Results
Team17 Group PLC	Half Year Results
Tern PLC	Half Year Results
ThinkSmart Ltd	Full Year Results
TP Group PLC	Half Year Results
Xaar PLC	Half Year Results
Wednesday 15 September
Advanced Medical Solutions Group PLC	Half Year Results
Anpario PLC	Half Year Results
BioPharma Credit PLC	Half Year Results
Central Asia Metals PLC	Half Year Results
Corero Network Security PLC	Half Year Results
Darktrace PLC	Full Year Results
Eleco PLC	Half Year Results
Epwin Group PLC	Half Year Results
Fevertree Drinks PLC	Half Year Results
IQGeo Group PLC	Half Year Results
Keywords Studios PLC	Half Year Results
Pendragon PLC	Half Year Results
Pharos Energy PLC	Half Year Results
Redrow PLC	Full Year Results
Restaurant Group PLC	Half Year Results
Ricardo PLC	Full Year Results
Science in Sport PLC	Half Year Results
Surgical Innovations Group PLC	Half Year Results
Trackwise Designs PLC	Half Year Results
Trinity Exploration & Production PLC	Half Year Results
Trustpilot Group PLC	Half Year Results
Tullow Oil PLC	Half Year Results
Thursday 16 September
Artisanal Spirits Company PLC	Half Year Results
Ashtead Group PLC	Q1 Results
Brooks Macdonald Group PLC	Full Year Results
Circassia Group PLC	Half Year Results
Clinigen Group PLC	Full Year Results
Duke Royalty Ltd	Full Year Results
Foresight Solar Fund Ltd	Half Year Results
Galliford Try Holdings PLC	Full Year Results
GENinCode PLC	Half Year Results
Hilton Food Group PLC	Half Year Results
IG Group Holdings PLC	Trading Statement
Keystone Law Group PLC	Half Year Results
Kier Group PLC	Full Year Results
Regional REIT PLC	Half Year Results
RTW Venture Fund Ltd	Half Year Results
Wickes Group PLC	Half Year Results

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

14 Jul 2020 09:07

Clinigen FY revenues continue to rise, profit growth slowed by Covid-19

(Sharecast News) - Pharmaceutical group Clinigen warned full-year profit growth would be at the lower end of guidance as a result of the Covid-19 pandemic and the launch of a low-cost competitor to its Foscavir drug.

13 Jul 2020 16:29

Clinigen gets orphan drug designation for 'aldesleukin' in the US

(Sharecast News) - Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug designation for 'aldesleukin', in the treatment of amyotrophic lateral sclerosis (ALS).

13 Jul 2020 13:48

Monday broker round-up

(Sharecast News) - Kingfisher: RBC Capital Markets reiterates outperform with a target price of 275.0p

13 Jul 2020 08:41

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

14 Jun 2020 19:22

Sunday newspaper round-up: Two meters, Rolls Royce, Clinigen

(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian

28 May 2020 13:34